Feature

New AACR President-Elect and Board Members Announced

The American Association for Cancer Research (AACR) has announced that Robert H. Vonderheide, MD, DPhil, has been named the 2026–2027 AACR President-elect. Dr. Vonderheide is an renowned cancer immuno...

Share

Robert H. Vonderheide, MD, DPhil, a prominent figure in cancer immunotherapy, has been elected the American Association for Cancer Research (AACR) President-elect for 2026–2027. He will officially assume the role in April 2026 during the AACR Annual Meeting in San Diego and will become President in April 2027 at the meeting in Orlando. A leader at the Abramson Cancer Center, he is recognized for his groundbreaking work in immunobiology and the development of novel cancer treatments, including telomerase vaccination and checkpoint blockade therapies.

Original Source(s)

New AACR President-Elect and Board Members Announced

  • by The ASCO Post Staff

  • March 18, 2026

Related Content

Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria

One in 10 patients who present to the emergency room (ER) with visible hematuria die within 3 months, new research from the United Kingdom has indicated. The WASHOUT study found that a scan administer...

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The combination of the NECTIN4-directed antibody drug conjugate enfortumab vedotin-ejfv and the immunotherapy drug pembrolizumab is the established first-line standard-of-care treatment for patients w...

Urine as a Cancer ‘Biopsy’?

Study traces tumor-derived extracellular vesicles from blood to urine through glomerular transport

  • March 18, 2026

  • 3 min